HWAIL PHARM. CO., LTD Logo

HWAIL PHARM. CO., LTD

Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.

061250 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단3길 57, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hwail Pharm. Co., Ltd. is a pharmaceutical company specializing in the research, development, manufacturing, and distribution of pharmaceutical raw materials (APIs). The company also produces and supplies finished drug formulations and functional ingredients. It emphasizes continuous R&D, stringent quality control, and transparent management to deliver high-quality products to the healthcare sector. Its product portfolio includes raw materials such as Talniflumate, Alibendol, and Oxatomide.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HWAIL PHARM. CO., LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 5.6 KB
2025-09-19 00:00
Regulatory News Service
본점소재지변경
Korean 5.1 KB
2025-09-04 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 10.8 KB
2025-09-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 37.7 KB
2025-08-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB

Automate Your Workflow. Get a real-time feed of all HWAIL PHARM. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HWAIL PHARM. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mezzion Pharma Co., Ltd. Logo
Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.
South Korea 140410
MFC Co., Ltd. Logo
A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.
South Korea 432980
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan 4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea 142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan 4534
Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.
South Korea 322970
MORISHITA JINTAN CO.,LTD. Logo
Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.
Japan 4524
MUROMACHI CHEMICALS INC. Logo
A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.
Japan 4885

Talk to a Data Expert

Have a question? We'll get back to you promptly.